Quesada S - Search Results

1

Dynamics of suspended sediment borne persistent organic pollutants in a large regulated Mediterranean river (Ebro, NE Spain).

Quesada S, Tena A, Guillén D, Ginebreda A, Vericat D, Martínez E, Navarro-Ortega A, Batalla RJ, Barceló D. Quesada S, et al. Sci Total Environ. 2014 Mar 1;473-474:381-90. doi: 10.1016/j.scitotenv.2013.11.040. Epub 2013 Dec 28. Sci Total Environ. 2014. PMID: 24380771 Free article.

2

Evaluating influenza vaccination campaigns beyond coverage: a before-after study among health care workers.

Llupià A, Mena G, Olivé V, Quesada S, Aldea M, Sequera VG, Ríos J, García-Basteiro AL, Varela P, Bayas JM, Trilla A. Llupià A, et al. Among authors: quesada s. Am J Infect Control. 2013 Aug;41(8):674-8. doi: 10.1016/j.ajic.2013.04.006. Am J Infect Control. 2013. PMID: 23896285

3

New interventions to increase influenza vaccination rates in health care workers.

Llupià A, García-Basteiro AL, Olivé V, Costas L, Ríos J, Quesada S, Varela P, Bayas JM, Trilla A. Llupià A, et al. Among authors: quesada s. Am J Infect Control. 2010 Aug;38(6):476-81. doi: 10.1016/j.ajic.2010.01.013. Epub 2010 Apr 24. Am J Infect Control. 2010. PMID: 20421140

4

[Adverse events self-declaration system and influenza vaccination coverage of healthcare workers in a tertiary hospital].

Velasco Munoz C, Sequera VG, Vilajeliu A, Aldea M, Mena G, Quesada S, Varela P, Olivé V, Bayas JM, Trilla A. Velasco Munoz C, et al. Among authors: quesada s. Med Clin (Barc). 2016 Feb 19;146(4):155-9. doi: 10.1016/j.medcli.2015.11.010. Epub 2015 Dec 22. Med Clin (Barc). 2016. PMID: 26726108 Spanish.

5

Economic Evaluation of Combining Pharmaco- and Behavioral Therapies for Smoking Cessation in an Occupational Medicine Setting.

Rejas-Gutiérrez J, López-Ibáñez de Aldecoa A, Casasola M, Varela P, Quesada S, Olive V, Arriaza E. Rejas-Gutiérrez J, et al. Among authors: quesada s. J Occup Environ Med. 2019 Apr;61(4):318-327. doi: 10.1097/JOM.0000000000001546. J Occup Environ Med. 2019. PMID: 30688765

6

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.

Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.

7

Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study).

Sáez-Peñataro J, Torres F, Bartra J, Bascuas J, Vilella A, Tortajada M, Quesada S, González E, López-Suñé E, Castells A, Serrano S, Camacho C, Trilla A, Calvo G; VigilVacCOVID Group. Sáez-Peñataro J, et al. Among authors: quesada s. BioDrugs. 2022 Jul;36(4):509-520. doi: 10.1007/s40259-022-00543-9. Epub 2022 Jun 28. BioDrugs. 2022. PMID: 35764768 Free PMC article.

8

Psychosocial and biological predictors of resident physician burnout.

Olivé V, Navinés R, Macías L, López JA, Ariz J, Quesada S, Barroso S, Filella X, Langohr K, Martin-Santos R. Olivé V, et al. Among authors: quesada s. Gen Hosp Psychiatry. 2022 Sep-Oct;78:68-71. doi: 10.1016/j.genhosppsych.2022.07.007. Epub 2022 Jul 22. Gen Hosp Psychiatry. 2022. PMID: 35901627

9

Integrative analysis of systemic lupus erythematosus biomarkers: Role of fecal hsa-mir-223-3p and gut microbiota in transkingdom dynamics.

Quesada S, Rosso AD, Mascardi F, Soler-Rivero V, Aguilera P, Mascuka SN, Boiro A, Arenielo E, Vijoditz G, Ferreyra-Mufarregue LR, Caputo MF, Cimolai MC, Coluccio Leskow F, Penas-Steinhardt A, Belforte FS. Quesada S, et al. Mol Immunol. 2024 May 24;171:77-92. doi: 10.1016/j.molimm.2024.05.004. Online ahead of print. Mol Immunol. 2024. PMID: 38795687

10

The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile?

Quesada S, Jacot W. Quesada S, et al. Ann Transl Med. 2023 Oct 25;11(11):393. doi: 10.21037/atm-23-1608. Epub 2023 Aug 29. Ann Transl Med. 2023. PMID: 37970606 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page